Frederiksberg Hospital

5 trials 2 recruiting Academic / non-commercial

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

3 Completed trials

1 Countries active

17 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 3

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

AZITHROMYCIN 1 BISOPROLOL FUMARATE 1 BOTULINUM TOXIN TYPE A 1 BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX 1 CARVEDILOL 1 CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS 1 LAMOTRIGINE 1 LITHIUM CARBONATE 1 METOPROLOL TARTRATE 1 NEBIVOLOL HYDROCHLORIDE 1 SODIUM CHLORIDE 1 TRASTUZUMAB 1

All trials

5 total

Botox Treatment for Patients with Hidradenitis Suppurativa: A Within-Person, Randomized, Double-blind, Controlled Study Recruiting

2024-519946-54-00 Phase IV 1 country BOTULINUM TOXIN TYPE A; BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX; CLOSTRI…
The LiLa-Bipolar RCT Recruiting

2023-509607-32-00 Phase IV 1 country LAMOTRIGINE; LITHIUM CARBONATE
COPD - Eosinophil-guided Reduction of Inhaled Corticosteroids (COPERNICOS) Ended

2022-501035-16-01 Phase IV 1 country AZITHROMYCIN
HERES trial: Trastuzumab and standard treatment with chemo- and immunotherapy as first line treatment for HER2 positive esophageal squamous … Ended

2024-516318-40-02 Phase II 1 country TRASTUZUMAB
Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) Ended

2024-515748-22-01 Phase III 1 country BISOPROLOL FUMARATE; CARVEDILOL; METOPROLOL TARTRATE; NEBIVOLOL HYDROCHLORIDE

Showing 1–5 of 5 trials

← All sponsors A–Z